Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SOND | Common Stock | Options Exercise | $41.2K | +46.3K | $0.89 | 46.3K | Sep 15, 2022 | Direct | ||
transaction | SOND | Common Stock | Sale | -$99.2K | -46.3K | -100% | $2.14 | 0 | Sep 15, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SOND | Employee stock option (right to buy) | Options Exercise | $0 | -46.3K | -100% | $0.00* | 0 | Sep 15, 2022 | Common Stock | 46.3K | $0.89 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple same day, same way open market sales transactions at prices ranging from $1.84 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4. |
F2 | The option grant was fully vested as of April 30, 2019. The option grant was set to expire on October 18, 2022. |